Retraction of “Design, Synthesis, and Biological Evaluation of Notopterol Derivatives as Triple Inhibitors of AChE/BACE1/GSK3β for the Treatment of Alzheimer’s Disease”
Saved in:
| Main Authors: | Nan Wang, Wenjie Liu, Lijun Zhou, Wenwu Liu, Xu Liang, Xin Liu, Zihua Xu, Tianming Zhong, Qiong Wu, Xinming Jiao, Jiangxia Chen, Xinyue Ning, Xiaowen Jiang, Qingchun Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Chemical Society
2025-07-01
|
| Series: | ACS Omega |
| Online Access: | https://doi.org/10.1021/acsomega.5c06137 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RETRACTED: Design, Synthesis, and Biological Evaluation of Notopterol Derivatives as Triple Inhibitors of AChE/BACE1/GSK3β for the Treatment of Alzheimer’s Disease
by: Nan Wang, et al.
Published: (2022-08-01) -
Effects of Ficus exasperata on neurotransmission and expression of BDNF, tau, ACHE and BACE in diabetic rats
by: Olorunsola Israel Adeyomoye, et al.
Published: (2024-12-01) -
Targeted delivery of BACE1 siRNA for synergistic treatment of Alzheimer's disease
by: Zhaohan Li, et al.
Published: (2025-08-01) -
The BACE‐1 inhibitor CNP520 for prevention trials in Alzheimer's disease
by: Ulf Neumann, et al.
Published: (2018-09-01) -
BACE1 as an early biomarker and its relevance to risk factors for Alzheimer’s disease
by: Masuo Ohno
Published: (2025-10-01)